Detection and treatment of multidrug resistant TB in India remains low
BMJ 2013; 347 doi: https://doi.org/10.1136/bmj.f5414 (Published 03 September 2013) Cite this as: BMJ 2013;347:f5414- Cheryl Travasso
- 1Mumbai
Only 6% of the estimated 66 000 cases of multidrug resistant tuberculosis (MDR-TB) in India in 2011 were detected, and only 5% of these patients were enrolled in second line treatment programmes, a study has found.
Although enrolment to treatment programmes of people in India with MDR-TB improved by over 50% a year between 2009 and 2011, the number of people being treated is still low in a country with one of the highest burdens of MDR-TB, says the report in Lancet Infectious Diseases.1
Mycobacterium tuberculosis is considered to be multidrug resistant when the strain is no longer sensitive to …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £173 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£38 / $45 / €42 (excludes VAT)
You can download a PDF version for your personal record.